Service

Technopole Chimie-Biologie-Santé

Hôtel D'Entreprises - Cs 70603 , 27106 Val de Reuil Cedex
France

Telephone +33 2 32255959
Fax +33 2 32255960
info@technopole-cbs.com

This company is co-exhibitor of
Business France

Trade fair hall

  • Hall 17 / C24
 Interactive Plan

Hall map

MEDICA 2016 hall map (Hall 17): stand C24

Fairground map

MEDICA 2016 fairground map: Hall 17

Our range of products

Product categories

  • 07  Medical Services and Publications
  • 07.04  Professional institutions
  • 07  Medical Services and Publications
  • 07.04  Professional institutions
  • 07.04.01  Associations and organisations

Associations and organisations

Our products

Product category: Professional institutions, Associations and organisations

The Chemistry Biology Health sector in Normandy

Key figures
  • France's 2nd most important region for pharmaceutical chemistry
  • France's 5th most important region for medicines production
  • Over 150 industrial establishments in the chemistry and pharmacy sectors
  • Presence of 3 of the world's leading groups in pharmaceuticals
  • 2 Scientific universities (Rouen, Le Havre)
  • 1 University hospital (Rouen) having a Clinical Investigation Centre
  • 2 000 Researchers and experts in the domain

More Less

About us

Company details

CBS Technopole was created in 2004 at the initiative of the Haute-Normandie Region to bring together and promote actors in the Chemistry-Biology-Health sector. It was labelled an Enterprise Cluster in 2009 by the Datar.

Today, the mission of CBS Technopole is to develop exchanges and collaborations between the research sector and companies in the Pharma/Health sectors within the Normandy / Centre / West-of-Paris geographical zone.

The services it offers are centered around two key axes:

  • support for growth and competitiveness in order to help develop the business of member companies (Business Dating days, international development, working groups, etc.) 
  • creation of Research Development Innovation (RDI) projects to facilitate interaction between industry and research, access to the European Horizon 2020 programme, and the deployment of major structural projects.

More Less